MMSI Merit Medical Systems Inc.

Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023

Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023

SOUTH JORDAN, Utah, July 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2023, after the close of the stock market on Tuesday, July 25, 2023.

Merit will hold its investor conference call on the same day (Tuesday, July 25, 2023) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).

To access the conference call, please pre-register using the following . Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this . A link to both register for the conference call and view the webcast will be made available at merit.com.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is a leading global manufacturer and marketer of healthcare technology. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 700 individuals. Merit employs approximately 7,100 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Contacts:       
   
PR/Media Inquiries:

Teresa Johnson

Merit Medical





 Investor Inquiries:

Mike Piccinino, CFA, IRC

Westwicke - ICR





   


EN
06/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Shareholders Elect Silvia M. Perez as New Director

Merit Medical Shareholders Elect Silvia M. Perez as New Director Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit’s Board of Directors SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and Transportation Division at 3M Company, as a director in Merit’s Annual Meeting of Shareholders held on May 15, 2024. Mer...

 PRESS RELEASE

Merit Medical Executive Leadership Team Update

Merit Medical Executive Leadership Team Update Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr. Wright will be responsible for the oversight of Merit’s global commercial, marketing, and manufacturing operations. Mr. Wright has been an instrumental part of the Merit team over ...

 PRESS RELEASE

Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug...

Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe New products broaden Merit’s leadership in embolotherapy.Full portfolio will be exhibited at the 18th Annual GEST Meeting May 16-19 in New York City. SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) clearance for its Siege Vascular Plug. Merit also announced the launch of its Bearing nsPVA Express Prefilled Syringe in the U...

 PRESS RELEASE

Merit Medical Reports Results for First Quarter Ended March 31, 2024

Merit Medical Reports Results for First Quarter Ended March 31, 2024 Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023Q1 2024 GAAP operating margin of 11.1%, compared to 8.9% in Q1 2023Q1 2024 non-GAAP operating margin* of 17.3%, compared to 16.1% in Q1 2023Q1 2024 GAAP EPS $0.48, up 35.5%, compared to $0.36 in Q1 2023Q1 2024 non-GAAP EPS* $0.77, up 18.7%, compared to $0.64 in Q1 2023 * Constant currency revenue; constant currency revenu...

 PRESS RELEASE

Merit Medical Launches the Micro ACE™ Advanced Micro-Access System

Merit Medical Launches the Micro ACE™ Advanced Micro-Access System Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases SOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. Merit also intends to file Micro ACE for CE mark designation. The Micro ACE system is the latest innovation in the Merit Vascular port...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch